-
Ocrevus-related MS Studies to be Presented at ECTRIMS 2018
Read about Genentech’s presentations at ECTRIMS 2018, including five-year efficacy and safety data of treatment of relapsing MS and PPMS with Ocrevus.
Click here to find out more about this.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.